Xiaoxing is an Analyst at Innosight. Xiaoxing is passionate about helping a great company continue to be great in the future.
Prior joining Innosight, Xiaoxing worked at Decision Resource Group, a market research and healthcare consulting firm, helped pharmaceutical companies understand the competitive landscape of their products and developed market launch strategies. Previously, Xiaoxing did her postdoctoral fellowship at Dana Farber Cancer Institute and Broad Institute. Her work involved identifying the Achilles heel of colon cancer by high throughput functional genomic screening, in which thousands of human genes can be individually manipulated and evaluated in parallel.
Xiaoxing likes to volunteer for organizations at the interphase among academia, industry and business. She served as Vice President of Harvard Graduate Consulting Club helping bridge consulting firms with Harvard community. Xiaoxing has also served as Council of Advisor for the Hope Funds for Cancer Research since 2011.
Xiaoxing received her B.S. in Biological Sciences from China Agricultural University and her Ph.D. in Environmental Health Sciences from New York University. She did her postdoctoral fellowship at Dana Farber Cancer Institute and Broad Institute.